Cytosorbents (CTSO) Change in Inventory (2011 - 2026)

Cytosorbents has reported Change in Inventory for 16 years, with the latest figure at -$723000.0 in Q1 2026.

• For the quarter ending Q1 2026, Change in Inventory fell 463.32% year-over-year to -$723000.0; the trailing twelve-month figure through Mar 2026 stood at $1.6 million (up 321.38% YoY), and the FY2025 full-year result was $2.5 million, up 608.0% from the prior year.
• Change in Inventory for Q1 2026 stood at -$723000.0, down from $1.3 million in the prior quarter.
• The five-year high for Change in Inventory was $1.3 million in Q4 2025, with the low at -$1.7 million in Q1 2023.
• Historically, Change in Inventory has averaged $11080.9 across 5 years, with a median of $288549.0 in 2023.
• Annual changes were most pronounced in 2025 — Change in Inventory soared 472.62% — and 2026, when it plunged 463.32%.
• Cytosorbents' Change in Inventory stood at -$485918.0 in 2022, then surged by 159.38% to $288549.0 in 2023, then sank by 220.26% to -$347000.0 in 2024, then soared by 472.62% to $1.3 million in 2025, then plunged by 155.92% to -$723000.0 in 2026.
• The last three Change in Inventory figures came in at -$723000.0 (Q1 2026), $1.3 million (Q4 2025), and $322000.0 (Q3 2025), per Business Quant data.